CCN1 overexpression is associated with the progression of various tumors, including prostate cancer, breast cancer, glioma, colorectal cancer, and osteosarcoma, through its ability to promote angiogenesis, cell migration or proliferation [28, 29]. This evidence concerns the gene CCN1 and osteosarcoma.